Well-designed Veterinary Ivermectin And Closantel Injection Supplier/Manufacturer - Furosemide Injection – Jizhong
Well-designed Veterinary Ivermectin And Closantel Injection Supplier/Manufacturer - Furosemide Injection – Jizhong Detail:
Furosemide injection
content
each 1 ml contains 25 mg furosemide.
indications
furosemide injection is used for the
treatment of all types of edema in cattle, horses,
camels, sheep, goats, cats and dogs. it is also used
in supporting the excretion of excessive fluid from
the body, as a result of its diuretic effect.
usage and dosage
species therapeutic dose
horses, cattle, camels 10 – 20 ml
sheep, goats 1 – 1.5 ml
cats, dogs 0.5 – 1.5 ml
note
it is administered via intravenous route (slow infusion) and intramuscular route. treatment should be continued for 3 days.
presentation
it is presented in 20 ml, 50 ml and 100 ml bottles inside cardboard boxes.
drug residue cautions
animals kept for meat should not be sent to slaughter throughout the treatment and within 5 days following the
last drug administration. milk of cows and goats obtained throughout the treatment and within 3 days (6 milkings)
following the last drug administration should not be offered to consumption by human.
target species
cattle, horse, camel, sheep, goat, cat, dog
Product detail pictures:

Related Product Guide:
Our growth depends on the superior equipment ,exceptional talents and continuously strengthened technology forces for Well-designed Veterinary Ivermectin And Closantel Injection Supplier/Manufacturer - Furosemide Injection – Jizhong , The product will supply to all over the world, such as: Nepal, Morocco, Canberra, If you are interested in any of our products or would like to discuss a custom order, please feel free to contact us. We are looking forward to forming successful business relationships with new clients around the world in the near future.

Hope that the company could stick to the enterprise spirit of "Quality, Efficiency, Innovation and Integrity", it will be better and better in the future.
